AN-2690 |
A3177-10 |
ApexBio |
10 mg |
EUR 164.4 |
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis. |
Ige Antibody Laboratories manufactures the is ig e an antibody reagents distributed by Genprice. The Is Ig E An Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ige antibody. Other Is products are available in stock. Specificity: Is Category: Ig Group: E An
AN-2728 |
ApexBio |
50 mg |
EUR 686.4 |
Description: AN-2728 is an inhibitor of PDE4 with IC50 value of 0.49 ?M [1]. PDE4 is a phosphodiesterase and plays an important role in the chronic inflammation associated with psoriasis and atopic dermatitis [2]. |
JBS True Blue |
MiTeGen |
300 µl |
EUR 16 |
Description: JBS True Blue |
Immunoglobulin (IG) Antibody |
Abbexa |
200 ug |
EUR 1011.6 |
|
E An information
Antimycin A4 |
A128-0.5MG |
TOKU-E |
0.5 mg |
EUR 326.4 |
Antimycin A4 |
A128-2.5MG |
TOKU-E |
2.5 mg |
EUR 1053.6 |
Antimony potassium tartrate trihydrate |
A100-2x25G |
TOKU-E |
2 x 25 g |
EUR 75.6 |
Antimony potassium tartrate trihydrate |
A100-4x25G |
TOKU-E |
4 x 25 g |
EUR 100.8 |
Immunoglobulin (IG) Antibody |
abx024071-200ug |
Abbexa |
200 ug |
EUR 1011.6 |
|
AN-2690 |
A3177-10 |
ApexBio |
10 mg |
EUR 164.4 |
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis. |
AN-2690 |
A3177-100 |
ApexBio |
100 mg |
EUR 699.6 |
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis. |
AN-2690 |
A3177-5 |
ApexBio |
5 mg |
EUR 129.6 |
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis. |
AN-2690 |
A3177-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis. |
AN-2690 |
A3177-50 |
ApexBio |
50 mg |
EUR 428.4 |
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis. |
AN-2728 |
A3178-10 |
ApexBio |
10 mg |
EUR 268.8 |
Description: AN-2728 is an inhibitor of PDE4 with IC50 value of 0.49 ?M [1]. PDE4 is a phosphodiesterase and plays an important role in the chronic inflammation associated with psoriasis and atopic dermatitis [2]. |
AN-2728 |
A3178-5 |
ApexBio |
5 mg |
EUR 219.6 |
Description: AN-2728 is an inhibitor of PDE4 with IC50 value of 0.49 ?M [1]. PDE4 is a phosphodiesterase and plays an important role in the chronic inflammation associated with psoriasis and atopic dermatitis [2]. |
AN-2728 |
A3178-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 234 |
Description: AN-2728 is an inhibitor of PDE4 with IC50 value of 0.49 ?M [1]. PDE4 is a phosphodiesterase and plays an important role in the chronic inflammation associated with psoriasis and atopic dermatitis [2]. |
AN-2728 |
A3178-50 |
ApexBio |
50 mg |
EUR 686.4 |
Description: AN-2728 is an inhibitor of PDE4 with IC50 value of 0.49 ?M [1]. PDE4 is a phosphodiesterase and plays an important role in the chronic inflammation associated with psoriasis and atopic dermatitis [2]. |